Literature DB >> 15463547

For a few parasites more: Inoculum size, vector control and strain-specific immunity to malaria.

J Lines1, J R Armstrong.   

Abstract

What precipitates malaria illness in an area of intense transmission? Greenwood, Marsh and Snow(1) and Marsh(2) have discussed the hypothesis that the severity of malaria depends on the size of the inoculum, that is, on the number of sporozoites inoculated at one time(3). According to these authors, this is suggested by the results of vector control trials in which parasite prevalence remained the same but episodes of disease were reduced. This is clearly an important observation, but Jo Lines and Jo Armstrong interpret it differently. They see the primary implication of these results as being that natural immunity to malaria must be largely strain specific, and only if there is strain specificity can inoculum size be important. Here they present arguments to support this view,and point out that, if there is strain specific immunity, then short-term evaluation o f vector control is likely to overestimate its long-term benefit.

Entities:  

Year:  1992        PMID: 15463547     DOI: 10.1016/0169-4758(92)90176-3

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  10 in total

1.  Decision support for malaria-control programmes--a system dynamics model.

Authors:  S Flessa
Journal:  Health Care Manag Sci       Date:  1999-07

Review 2.  Economic aspects of the use of impregnated mosquito nets for malaria control.

Authors:  U Brinkmann; A Brinkmann
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 3.  Current status of malaria and potential for control.

Authors:  R S Phillips
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.

Authors:  George M Warimwe; Linda M Murungi; Gathoni Kamuyu; George M Nyangweso; Juliana Wambua; Vivek Naranbhai; Helen A Fletcher; Adrian V S Hill; Philip Bejon; Faith H A Osier; Kevin Marsh
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.

Authors:  F H A Osier; L M Murungi; G Fegan; J Tuju; K K Tetteh; P C Bull; D J Conway; K Marsh
Journal:  Parasite Immunol       Date:  2010-03       Impact factor: 2.280

6.  Measuring the effects of an ever-changing environment on malaria control.

Authors:  Thomas F McCutchan; K Christiana Grim; Jun Li; Walter Weiss; Darmendar Rathore; Margery Sullivan; Thaddeus K Graczyk; Sanjai Kumar; Mike R Cranfield
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

7.  Etiology of Placental Plasmodium falciparum Malaria in African Women.

Authors:  Michael F Ofori; Helena Lamptey; Emmanuel K Dickson; Eric Kyei-Baafour; Lars Hviid
Journal:  J Infect Dis       Date:  2018-06-20       Impact factor: 5.226

Review 8.  Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it.

Authors:  Anja Ramstedt Jensen; Yvonne Adams; Lars Hviid
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

9.  Uncovering drivers of dose-dependence and individual variation in malaria infection outcomes.

Authors:  Tsukushi Kamiya; Megan A Greischar; David S Schneider; Nicole Mideo
Journal:  PLoS Comput Biol       Date:  2020-10-08       Impact factor: 4.475

10.  Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants.

Authors:  Amanda Ross; Melissa Penny; Nicolas Maire; Alain Studer; Ilona Carneiro; David Schellenberg; Brian Greenwood; Marcel Tanner; Thomas Smith
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.